Pasithea Therapeutics

About:

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.

Website: https://pasitheaclinics.com/

Top Investors: FightMND

Description:

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health. The company is led by renowned immunologists based at Stanford University and their academic research is headed by a top psychiatric academic at King’s College London. The long-term aim is to translate research into clinic-ready drugs. Pasithea Therapeutics' secondary operations focus on establishing anti-depression clinics and mobile clinics across the US and UK, using trained pharmacists to administer intravenous infusions of ketamine. Pasithea has partnered with two successful clinics (THE IV DOC and Zen Health) for immediate exposure in locations across Los Angeles, New York City, and London.

Total Funding Amount:

$36.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Venice, California, United States

Founded Date:

2020-01-01

Founders:

Lawrence Steinman

Number of Employees:

11-50

Last Funding Date:

2024-09-26

IPO Status:

Public

Industries:

© 2025 bioDAO.ai